ClearPoint Neuro, Inc. (CLPT) vs 908 Devices Inc. (MASS)
ClearPoint Neuro, Inc. and 908 Devices Inc. are both Medical Devices companies. 908 Devices Inc. is the larger, with a market value of $492.7M against $445.7M — 1.1× the size. ClearPoint Neuro, Inc. grew revenue faster over the last twelve months: 25.9% against 13.4%. 908 Devices Inc. has the higher net margin (−57.0% vs −81.8%) and the lower return on invested capital (−96.4% vs −61.3%). Across the 18 metrics below, 908 Devices Inc. leads on 11 and ClearPoint Neuro, Inc. on 7.
Valuation
Profitability
| Metric | CLPT | MASS | Medical Devices median |
|---|---|---|---|
| Gross margin | 62.61% | 52.16% | 56.01% |
| Operating margin | (73.42%) | (63.98%) | (15.03%) |
| Net margin | (81.76%) | (56.96%) | (20.40%) |
| Free cash flow margin | (74.01%) | 1.01% | (7.24%) |
| Return on equity | (226.52%) | (25.15%) | (15.32%) |
| Return on assets | (46.21%) | (17.81%) | (19.72%) |
| Return on invested capital | (61.31%) | (96.41%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack